Jaguar Health (JAGX) Change in Accured Expenses (2014 - 2026)
Jaguar Health (JAGX) posted quarterly Change in Accured Expenses of $41000.0 for Q1 2026, down 70.92% year-over-year from $141000.0 in Q1 2025, and up 177.36% quarter-over-quarter from -$53000.0 in Q4 2025.
Jaguar Health (JAGX) Change in Accured Expenses (2014 - 2026) Analysis & Trends
Jaguar Health (JAGX) has reported Change in Accured Expenses for 13 consecutive years, with $41000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Accured Expenses fell 70.92% year-over-year to $41000.0; the TTM figure through Mar 2026 stood at $2.0 million (up 228.6% YoY), while the FY2025 annual figure was $2.1 million, up 281.79% from the prior year.
- Change in Accured Expenses climbed to $41000.0 in Q1 2026 per JAGX's latest filing, from -$53000.0 in the prior quarter.
- Across five years, Change in Accured Expenses topped out at $3.3 million in Q1 2022 and bottomed at -$6.7 million in Q3 2023.
- Historically, Change in Accured Expenses has averaged -$138176.5 across 5 years, with a median of $41000.0 in 2026.
- Annual changes were most pronounced in 2022 — Change in Accured Expenses plunged 5724.0% — and 2025, when it surged 1017.2%.
- Jaguar Health's Change in Accured Expenses stood at -$1.9 million in 2022, then jumped by 125.32% to $473000.0 in 2023, then slumped by 352.85% to -$1.2 million in 2024, then surged by 95.57% to -$53000.0 in 2025, then jumped by 177.36% to $41000.0 in 2026.
- Business Quant data shows JAGX's Change in Accured Expenses at $41000.0 in Q1 2026, -$53000.0 in Q4 2025, and $528000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 222.50 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 492.70 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 11.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 212.44 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 61.62 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 68.82 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Jaguar Health | 447,549.24 | -9.62 Mn | 19.11 Mn | 41,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 41,000.00 |
| Mar 31, 2026 | 41,000.00 |
| Dec 31, 2025 | -53,000.00 |
| Dec 31, 2025 | -53,000.00 |
| Sep 30, 2025 | 528,000.00 |
| Sep 30, 2025 | 528,000.00 |
| Jun 30, 2025 | 1.44 Mn |
| Jun 30, 2025 | 1.44 Mn |
| Mar 31, 2025 | 141,000.00 |
| Mar 31, 2025 | 141,000.00 |
| Dec 31, 2024 | -1.20 Mn |
| Dec 31, 2024 | -1.20 Mn |
| Sep 30, 2024 | -309,000.00 |
| Sep 30, 2024 | -309,000.00 |
| Jun 30, 2024 | -157,000.00 |
| Jun 30, 2024 | -157,000.00 |
| Mar 31, 2024 | 531,000.00 |
| Mar 31, 2024 | 531,000.00 |
| Dec 31, 2023 | 473,000.00 |
| Dec 31, 2023 | 473,000.00 |